Coursera Spring Sale
40% Off Coursera Plus Annual!
Grab it
This 13-minute conference talk from the Cancer Genomics Consortium (CGC) 2024 Annual Meeting explores the clinical impact of establishing in-house molecular testing capabilities for underserved cancer patients in southern Alabama. Dr. Thuy Phung discusses how local genomic testing infrastructure affects cancer diagnosis accuracy, treatment selection, and patient outcomes in resource-limited settings. Learn about the challenges and solutions implemented to bring advanced molecular diagnostics to a region with significant healthcare disparities, and understand how this model might be applied to other underserved communities. The presentation aligns with CGC's mission of promoting best practices in clinical cancer genomics and ensuring all cancer patients receive accurate genomic diagnoses to guide appropriate therapy selection.
